State Ledger
Company profile

GYRE THERAPEUTICS, INC. CIK 1124105

Ticker
GYRE (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
San Diego, CA 92130
Fiscal year end
2025 (FY)
Market Data
Close
$6.73
Change
-$0.14
Change %
-2.04%
Volume
4,047

GYRE · trading date Oct 13, 2026 · previous close $6.87 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$116.59M
Net income
$9.88M
Total assets
$166.13M
Total liabilities
$23.85M
Stockholders' equity
$106.03M
Cash & equivalents
$37.07M
Operating income
$11.49M
Operating cash flow
$1.01M
Capital expenditures
$1.19M

Fiscal year 2025, via 10-K filed 2026-03-13. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
9.9%
Net margin
8.5%
Free cash flow
-$180.0K
Free cash flow margin
-0.2%
Liabilities / assets
14.4%
Equity / assets
63.8%
CapEx / revenue
1.0%
Operating cash flow / net income
0.10×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $116.59M $9.88M $166.13M $23.85M $106.03M
2024 $105.76M $17.90M $125.41M $27.00M $63.32M
2023 $113.45M -$85.48M $116.54M $38.07M -$15.83M
2022 $102.29M $4.31M $84.75M $12.54M $42.52M
2021 $7.34M -$87.93M $55.66M $14.57M $41.09M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-01
Financials filed via
Form 10-K
filed 2026-03-13

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
San Diego, CA 92130
12730 HIGH BLUFF DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:15 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies